- Home
- AMSC vs CDNA Comparison
AMSC vs CDNA Comparison
Compare AMSC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMSC
- CDNA
- Stock Information
- Founded
- AMSC 1987
- CDNA 1998
- Country
- AMSC United States
- CDNA United States
- Employees
- AMSC N/A
- CDNA N/A
- Industry
- AMSC Metal Fabrications
- CDNA Medical Specialities
- Sector
- AMSC Consumer Discretionary
- CDNA Health Care
- Exchange
- AMSC Nasdaq
- CDNA Nasdaq
- Market Cap
- AMSC 1.1B
- CDNA 1.0B
- IPO Year
- AMSC 1991
- CDNA 2014
- Fundamental
- Price
- AMSC $39.32
- CDNA $20.13
- Analyst Decision
- AMSC Strong Buy
- CDNA Buy
- Analyst Count
- AMSC 3
- CDNA 6
- Target Price
- AMSC $33.67
- CDNA $30.33
- AVG Volume (30 Days)
- AMSC 1.2M
- CDNA 866.7K
- Earning Date
- AMSC 08-05-2025
- CDNA 07-30-2025
- Dividend Yield
- AMSC N/A
- CDNA N/A
- EPS Growth
- AMSC N/A
- CDNA N/A
- EPS
- AMSC 0.16
- CDNA 1.07
- Revenue
- AMSC $222,818,000.00
- CDNA $346,421,000.00
- Revenue This Year
- AMSC $20.26
- CDNA $13.31
- Revenue Next Year
- AMSC $12.73
- CDNA $15.46
- P/E Ratio
- AMSC $245.25
- CDNA $18.99
- Revenue Growth
- AMSC 52.99
- CDNA 25.92
- 52 Week Low
- AMSC $13.98
- CDNA $14.09
- 52 Week High
- AMSC $41.10
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- AMSC 71.47
- CDNA 58.32
- Support Level
- AMSC $38.45
- CDNA $18.37
- Resistance Level
- AMSC $40.53
- CDNA $20.91
- Average True Range (ATR)
- AMSC 2.11
- CDNA 0.80
- MACD
- AMSC 0.14
- CDNA 0.06
- Stochastic Oscillator
- AMSC 86.91
- CDNA 69.88
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.